Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

DAIICHI S : Notice on Details of the Share Options

07/12/2011 | 04:20am US/Eastern
Recommend:
0
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126

http://www.daiichisankyo.com/Notice on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)

Reference

Date of Board of Directors resolution: June 27, 2011

###
Recommend :
0
React to this article
Latest news on DAIICHI SANKYO COMPANY, LI
5h ago RANBAXY LABORATORIES : Ceo sweetener a bitter pill for proxy firm
9h ago Ranbaxy, cipher join hands for brazil venture
3d ago Ranbaxy signs deal with cipher to sell acne drug
6d ago NPPA moves to bring cancer drugs under price control regime
6d ago Mckinsey hired to assist merger of sun, ranbaxy
6d ago RANBAXY LABORATORIES : Sun pharma-ranbaxy &4-billion deal gets bse, nse approval
07/18 Sun pharma buys us injectables company
07/16 RANBAXY LABORATORIES : Glenmark joins pharma companies setting up US plants
07/16 Nppa caps prices of 108 diabetes, cardiac drugs
07/10 RANBAXY LABORATORIES : INDIAN PHARMA'S US TRIPPING BENEFITS MNCs
Advertisement
Chart
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Income Statement Evolution
DAIICHI SANKYO COMPANY, LI : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF